Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference

Rhea-AI Summary

Foghorn Therapeutics (Nasdaq: FHTX) announced that management will participate in the 8th Annual Evercore Healthcare Conference in Coral Gables, FL, December 2-4, 2025.

The company said a Fireside Chat with Adrian Gottschalk, president and CEO, is scheduled for Thursday, December 4, 2025 at 9:10 a.m. EST. Management will also hold one-on-one meetings. A webcast of the presentation will be available under Events & Presentations on the company website and will be accessible for 30 days.

CAMBRIDGE, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the 8^th Annual Evercore Healthcare Conference, being held December 2-4, 2025, in Coral Gables, FL. With an initial focus in oncology, Foghorn’s Gene Traffic Control® platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases.

Fireside Chat Date and Time: Thursday December 4, 2025, at 9:10 a.m. EST

• Presenter: Adrian Gottschalk, President and Chief Executive Officer
• Please find a link to the webcast here
• Management will also participate in one-on-one meetings
  
  

A webcast of the presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website, www.foghorntx.com, and will be available for 30 days.

About Foghorn Therapeutics
Foghorn^® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control^® platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The Company is developing multiple product candidates in oncology. Visit our website at www.foghorntx.com for more information on the Company, and follow us on X and LinkedIn.

Contact:
Karin Hellsvik, Foghorn Therapeutics Inc. khellsvik@foghorntx.com

FAQ

When will Foghorn Therapeutics (FHTX) speak at the Evercore Healthcare Conference?

Management will participate December 2-4, 2025, with a Fireside Chat on Dec 4, 2025 at 9:10 a.m. EST.

Who will present for Foghorn Therapeutics (FHTX) at the conference?

Adrian Gottschalk, president and CEO, is listed as the presenter for the Fireside Chat.

How can investors watch the Foghorn Therapeutics (FHTX) webcast from the Evercore conference?

The webcast will be available under Events & Presentations in the Investors section of www.foghorntx.com.

How long will the Foghorn Therapeutics (FHTX) webcast be available after the Evercore presentation?

The company said the webcast will be available for 30 days after the presentation.

Will Foghorn Therapeutics (FHTX) hold investor meetings at the Evercore Healthcare Conference?

Yes, management will participate in one-on-one meetings in addition to the Fireside Chat.